Since the majority of IDHmut gliomas have methylation-induced suppression of the gene encoding the DNA repair enzyme O-6-Methylguanine-DNA Methyltransferase (MGMT), the DNA alkylating agent temozolomide (TMZ) is a mainstay of therapy in these tumors (3–5). Here, MGMT is linked to central nervous system cancer.